José Luis
Díaz Díaz
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (8)
2023
-
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study
European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 320-328
2020
-
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834
2019
-
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Atherosclerosis, Vol. 285, pp. 17-22
2018
-
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study
Journal of Clinical Lipidology, Vol. 12, Núm. 4, pp. 948-957
-
Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: The ESPARTA study
Journal of Comparative Effectiveness Research, Vol. 7, Núm. 3, pp. 223-232
2017
-
Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)
Circulation, Vol. 135, Núm. 22, pp. 2133-2144
2016
-
Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry
Journal of Clinical Lipidology, Vol. 10, Núm. 4, pp. 953-961
2002
-
Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases
Medicina Clinica, Vol. 118, Núm. 13, pp. 487-492